The regulation of expression of human beta-globin genes. 1987

F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
Laboratory of Gene Structure and Expression, National Institute for Medical Research, Mill Hill, London, U.K.

We have analyzed the regulation of expression of the human beta-globin gene by DNA mediated gene transfer in MEL cells and microinjection in fertilized mouse eggs. The results show that the beta-globin gene contains two regulatory elements: one element in the promoter, that is required for full transcriptional activity and, secondly, a tissue and developmental specific enhancer 3' to the gene.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D004742 Enhancer Elements, Genetic Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a promoter. Enhancer Elements,Enhancer Sequences,Element, Enhancer,Element, Genetic Enhancer,Elements, Enhancer,Elements, Genetic Enhancer,Enhancer Element,Enhancer Element, Genetic,Enhancer Sequence,Genetic Enhancer Element,Genetic Enhancer Elements,Sequence, Enhancer,Sequences, Enhancer
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
September 1987, Blood,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
January 1985, Oxford surveys on eukaryotic genes,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
January 1985, Annual review of biochemistry,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
July 1985, The EMBO journal,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
January 1986, Journal of cell science. Supplement,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
November 1999, Pathology,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
March 1991, Nature,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
December 1995, Australian and New Zealand journal of medicine,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
January 1987, Progress in clinical and biological research,
F Grosveld, and M Antoniou, and G B van Assendelft, and E de Boer, and J Hurst, and G Kollias, and F MacFarlane, and N Wrighton
March 1993, Bailliere's clinical haematology,
Copied contents to your clipboard!